These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 16377466)

  • 1. New anticoagulant agents: direct thrombin inhibitors.
    Nutescu EA; Shapiro NL; Chevalier A
    Clin Geriatr Med; 2006 Feb; 22(1):33-56, viii. PubMed ID: 16377466
    [TBL] [Abstract][Full Text] [Related]  

  • 2. New anticoagulant agents: direct thrombin inhibitors.
    Nutescu EA; Shapiro NL; Chevalier A
    Cardiol Clin; 2008 May; 26(2):169-87, v-vi. PubMed ID: 18406993
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antithrombin agents as anticoagulants and antithrombotics: implications in drug development.
    Fareed J; Callas D; Hoppensteadt DA; Lewis BE; Bick RL; Walenga JM
    Semin Hematol; 1999 Jan; 36(1 Suppl 1):42-56. PubMed ID: 9930564
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Direct thrombin inhibitors for anticoagulation.
    Nutescu EA; Wittkowsky AK
    Ann Pharmacother; 2004 Jan; 38(1):99-109. PubMed ID: 14742803
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The mechanism of action of thrombin inhibitors.
    Bates SM; Weitz JI
    J Invasive Cardiol; 2000 Dec; 12 Suppl F():27F-32. PubMed ID: 11156731
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Survival of heparins, oral anticoagulants, and aspirin after the year 2010.
    Fareed J; Hoppensteadt DA; Fareed D; Demir M; Wahi R; Clarke M; Adiguzel C; Bick R
    Semin Thromb Hemost; 2008 Feb; 34(1):58-73. PubMed ID: 18393143
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ximelagatran: pharmacokinetics and pharmacodynamics of a new strategy for oral direct thrombin inhibition.
    Kereiakes DJ
    Rev Cardiovasc Med; 2004; 5 Suppl 5():S4-11. PubMed ID: 15619615
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Emerging anticoagulants: mechanism of action and future potential.
    Klement P; Rak J
    Vnitr Lek; 2006 Mar; 52 Suppl 1():119-22. PubMed ID: 16637459
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Changing trends in anti-coagulant therapies. Are heparins and oral anti-coagulants challenged?
    Fareed J; Iqbal O; Cunanan J; Demir M; Wahi R; Clarke M; Adiguzel C; Bick R
    Int Angiol; 2008 Jun; 27(3):176-92. PubMed ID: 18506123
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Heparin chain-length dependence of factor Xa inhibition by antithrombin in plasma.
    Rezaie AR
    Thromb Res; 2007; 119(4):481-8. PubMed ID: 16515805
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Novel oral anticoagulants.
    Khoo CW; Tay KH; Shantsila E; Lip GY
    Int J Clin Pract; 2009 Apr; 63(4):630-41. PubMed ID: 19222611
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The new anticoagulants.
    Stone WM; Tonnessen BH; Money SR
    Perspect Vasc Surg Endovasc Ther; 2007 Sep; 19(3):332-5. PubMed ID: 17911567
    [TBL] [Abstract][Full Text] [Related]  

  • 13. New antithrombin-based anticoagulants.
    Desai UR
    Med Res Rev; 2004 Mar; 24(2):151-81. PubMed ID: 14705167
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Control of anticoagulant and antiplatelet therapy. Managing patients with acute thrombotic disorders.
    Anderson DR; Fernandez LA
    Can Fam Physician; 1993 Feb; 39():290-4, 297-300, 303-4. PubMed ID: 8495120
    [TBL] [Abstract][Full Text] [Related]  

  • 15. New antithrombotic drugs: potential for use in oncology.
    Levine MN
    J Clin Oncol; 2009 Oct; 27(29):4912-8. PubMed ID: 19738103
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Review of Direct Oral Anticoagulants and Guide for Effective Drug Utilization.
    Khachatryan T; Hauschild C; Hoff J; Contractor T; Khachatryan A; Tran H; Matsuo B; Jacobson A; Hilliard A
    Am J Cardiovasc Drugs; 2019 Dec; 19(6):525-539. PubMed ID: 30941708
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Direct thrombin inhibitors (part 1 of 2).
    Arora UK; Dhir M
    J Invasive Cardiol; 2005 Jan; 17(1):34-8. PubMed ID: 15640538
    [No Abstract]   [Full Text] [Related]  

  • 18. Anticoagulant treatment of deep vein thrombosis and pulmonary embolism.
    Tran H; McRae S; Ginsberg J
    Clin Geriatr Med; 2006 Feb; 22(1):113-34, ix. PubMed ID: 16377470
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An algal sulfated galactan has an unusual dual effect on venous thrombosis due to activation of factor XII and inhibition of the coagulation proteases.
    Melo FR; Mourão PA
    Thromb Haemost; 2008 Mar; 99(3):531-8. PubMed ID: 18327401
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Oral anticoagulation with factor Xa and thrombin inhibitors: on the threshold of change.
    Zikria JC; Ansell J
    Curr Opin Hematol; 2009 Sep; 16(5):347-56. PubMed ID: 19550318
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.